-

Thermo Fisher Scientific Launches New ENERGY STAR certified TSX Universal Series ULT Freezers to Deliver Tighter Temperature Control and Faster Recovery Times

Enhanced performance and 33% energy savings support quality and sustainability goals in the laboratory

CARLSBAD, Calif.--(BUSINESS WIRE)--Building on 80 years of expertise engineering cold storage lab equipment, Thermo Fisher Scientific today introduces its newest line of high performance, ultra-low temperature (ULT) freezers. With enhancements to performance, user experience and energy efficiency, the Thermo Scientific™ TSX™ Universal Series ULT Freezers seamlessly adapt to scientists’ workflows across a variety of lab settings, marking a new era in performance, reliability, and sustainability.

Laboratories require reliable and effective cold storage solutions for their samples, often at a very specific temperature range, to advance critical research, adequately store samples or accelerate the development of new therapies. With Universal V-Drive technology, tighter control, faster recovery times, universal voltage, and an expanded setpoint range, the TSX Universal Series seamlessly adapts to diverse workflows, from high-use academic labs to longer-term storage facilities. Delivering both industry leading performance and energy efficiency, the TSX Universal Series allows labs to meet their sustainability goals without sacrificing performance.

“With the advancement of new therapeutic technologies and tighter regulatory focus on the pharmaceutical cold chain, there’s a clear need for enhanced and manageable cold storage solutions across a variety of settings,” said Carlos Sevilla, vice president and general manager, Controlled Temperature Technologies at Thermo Fisher Scientific. “Following extensive research and development, we’re proud to launch the next generation TSX Universal Series of ULTs, enabling high-use academic labs, GMP labs and long-term storage facilities to use the same unit throughout diverse workflows while supporting their own sustainability goals.”

TSX Universal Series ULT freezers undergo rigorous long-term reliability testing, having undergone +5400 combined days of continuous reliability testing in the field and laboratory environments to help ensure each unit meets Thermo Fisher Scientific's stringent quality standards. ENERGY STAR® certified and produced in a Zero-Waste to Landfill certified facility, the TSX Universal Series ULT freezers are designed with sustainability in mind and provide easy-to-use information about the products' environmental impact through the ACT label program, run by the non-profit organization My Green Lab.

For the first time, the TSX Series ULT platform offers medical device units, to store and preserve blood and blood products at freezing temperatures between -40°C to -86°C for users operating in GMP or qualified environments.* By obtaining ISO Class 5.5 cleanroom designation for TSX Universal Series ULT freezers, cell and gene therapy customers can have confidence in the cleanliness and control of their storage environments. Additionally, customers can benefit from an industry-leading warranty and global service support through Unity Lab Services.

To learn more about the new TSX Universal Series ULTs, please visit www.thermofisher.com/TSXUniversalULT

*Registered as a medical device in the US only. Verification of medical devices in the U.S. can be found on: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfrl/rl.cfm

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Contacts

Media Contact Information:
Shannon Stoneking
Phone: 484-748-1279
E-mail: shannon.stoneking@thermofisher.com

Jessika Parry
Phone: 419-266-4016
Email: jparry@greenoughagency.com

Thermo Fisher

NYSE:TMO
Details
Headquarters: Waltham, Massachusetts
CEO: Marc N. Casper
Employees: 100,000
Organization: PUB
Revenues: $40 Billion (2021)

Release Versions

Contacts

Media Contact Information:
Shannon Stoneking
Phone: 484-748-1279
E-mail: shannon.stoneking@thermofisher.com

Jessika Parry
Phone: 419-266-4016
Email: jparry@greenoughagency.com

More News From Thermo Fisher

Thermo Fisher Scientific Announces Quarterly Dividend

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share, payable on October 15, 2026, to shareholders of record as of September 15, 2026. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world h...

Thermo Fisher Scientific Receives First FBI Approval for Rapid DNA Crime Scene Profiles Eligible for National CODIS Searches

SAN FRANCISCO--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced that the Applied Biosystems™ RapidINTEL™ Plus Cartridge has received approval from the Federal Bureau of Investigation (FBI) National DNA Index System (NDIS) for use with qualifying forensic crime scene samples. The law enforcement milestone makes Thermo Fisher's Rapid DNA workflow on the RapidHIT ID™ System the first eligible to generate DNA profiles that can be searched against the n...

Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the second quarter 2026 before the market opens on Thursday, July 23, 2026, and will hold a conference call on the same day at 8:30 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. The call will be webcast live on the “Investors” section of our website, www.thermofish...
Back to Newsroom